Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Transitional Cell 9Carcinoma, Merkel Cell 7Neoplasm Metastasis 6Breast Neoplasms 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Melanoma 4Urethral Neoplasms 3Ureteral Neoplasms 3Skin Neoplasms 3Carcinoma, Renal Cell 3Ovarian Neoplasms 2Neuroendocrine Tumors 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thymoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Peritoneal Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Motor Activity 1Microsatellite Instability 1

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 4Cisplatin 4Biopsy 4selpercatinib 3larotrectinib 3Vincristine 3Carboplatin 3erdafitinib 2ensartinib 2Temozolomide 2Radiotherapy 2Methotrexate 2Cyclophosphamide 2Chemotherapy, Adjuvant 2ulixertinib 1tipifarnib 1tazemetostat 1palbociclib 1olaparib 1niraparib 1neratinib 1lenvatinib 1ivosidenib 1ibrutinib 1entrectinib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Central Nervous System Neoplasms × avelumab × Clear all
NCT05081180 2026-05-01

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

EMD Serono

Phase 1 Active not recruiting
17 enrolled
CNS

Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡